Branched-chain amino acid catabolism, glucose-6-phosphate dehydrogenase deficiency, ribose-5-phosphate isomerase deficiency, transaldolase deficiency, the valproic acid metabolism pathway, and the valproic acid pathway were found to be significantly impacted (p < 0.05). The gene discussed is RPIA; the disease is transaldolase deficiency.